Until the early 2000s, advanced or metastatic non–small cell lung cancer (NSCLC ... the treatment of NSCLC tumors with specific oncogene drivers or molecular alterations. Molecular testing has become ...
More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.
American Lung Association’s ‘State of Lung Cancer’ report reveals stark differences in survival, screening and treatment across states ...
Biofidelity, a leader in innovative genomic solutions, today announced the launch of Aspyre Clinical Test for Lung for liquid biopsy samples. Aspyre Clinical Test for Lung analyzes all ...
AstraZeneca, in partnership with the Moi Teaching & Referral Hospital (MTRH), has launched an advanced molecular testing ...
Louisiana residents have one of the highest lung cancer death rates in the country, even as groundbreaking treatments in ...
2don MSN
More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.
Today, the American Lung Association released its 2024 “State of Lung Cancer” report, which examines key indicators to highlight how the toll of lung cancer varies by state. Lung cancer is the leading ...
More people with lung cancer are living longer, but it remains America's deadliest cancer, a new state-by-state report shows.
CHICAGO, Nov. 19, 2024 /PRNewswire/ -- Lung cancer is the leading cause of the cancer deaths in the U.S., but the American Lung Association's 2024 "State of Lung Cancer" report reveals positive news.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback